Even though doxycycline postexposure prophylaxis (PEP) has been shown to prevent sexually transmitted infections (STIs) among cisgender men and transgender women, a randomized trial in 449
Men who use phosphodiesterase 5 (PDE5) inhibitors may father more children, a genetic study reports. The authors believe this finding could have implications in countries
Over 12 months at 30 U.K. general practices, men who received a standardized and manualized intervention had a sustained reduction in lower urinary tract symptoms
Compared in a phase 3 trial with gemcitabine–cisplatin in patients with untreated unresectable or metastatic urothelial carcinoma, nivolumab plus gemcitabine–cisplatin resulted in significantly better outcomes,
Compared with leuprolide therapy alone, enzalutamide plus leuprolide improved metastasis-free survival in patients with prostate cancer with high-risk biochemical recurrence, a study shows. “Enzalutamide monotherapy
In the TRAVERSE trial, testosterone-replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events in men aged 45 to
Reducing unnecessary urine cultures through diagnostic stewardship is an effective way of reducing antibiotic treatment of patients with asymptomatic bacteriuria (ASB), according to findings of
Regardless of the treatment chosen, men with localized prostate cancer had low mortality and similar outcomes after a median of 15 years of follow-up, researchers
In patients with metastatic, castration-resistant prostate cancer with a BRCA alteration, rucaparib produced significantly increased progression-free survival compared with physician’s choice of a control medication, TRITON3 investigators
Compared with piperacillin/tazobactam in the phase 3 ALLIUM trial, cefepime/enmetazobactam met the criteria for noninferiority as well as superiority for clinical cure and microbiological eradication